Newsletter- July 2018

  • The Supreme Court says the Patent Act, which generally extends only to conduct occurring within the U.S., allows for enforcement of a U.S. patent against one specific overseas activity—the supplying of U.S.-made components to be assembled overseas in an infringing device. More. . . 
  • A PTO memorandum, relying on a recent Federal Circuit decision, provides the life sciences industry with guidance on how to qualify method-of-treatment claims as patent-eligible subject matter. More. . .
  • The recently signed Right to Try Act enables terminally ill patients to try experimental drugs that have completed Phase I testing but have not been approved by the FDA. It adds but little to existing “compassionate use” programs. More. . .
  • A new study correlates companies’ pursuit of trademark registrations with the growth of their businesses. More. . .
  • California’s new data privacy law requires many of the same protections that recently took effect in the EU. More. . .